866-997-4948(US-Canada Toll Free)

China Anti-Obesity Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

Notes:
Sales, means the sales volume of Anti-Obesity Drugs
Revenue, means the sales value of Anti-Obesity Drugs

This report studies Anti-Obesity Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Prescription Drugs
OTC Drugs
Split by Application, this report focuses on consumption, market share and growth rate of Anti-Obesity Drugs in each application, can be divided into
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

Table of Contents

China Anti-Obesity Drugs Market Research Report 2017
1 Anti-Obesity Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Anti-Obesity Drugs Segment by Type
1.2.1 China Production Market Share of Anti-Obesity Drugs Type in 2015
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Applications of Anti-Obesity Drugs
1.3.1 Anti-Obesity Drugs Consumption Market Share by Application in 2015
1.3.2 6-18 Callant
1.3.3 18-30 Adult
1.3.4 30-60Middle-Aged
1.3.5 Others
1.4 China Market Size (Value) of Anti-Obesity Drugs (2012-2022)
1.5 China Anti-Obesity Drugs Status and Outlook
1.6 Government Policies

2 China Anti-Obesity Drugs Market Competition by Manufacturers
2.1 China Anti-Obesity Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Anti-Obesity Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Anti-Obesity Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-Obesity Drugs Market Concentration Rate
2.5.2 Anti-Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Anti-Obesity Drugs Manufacturers Profiles/Analysis
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Anti-Obesity Drugs Product Type, Application and Specification
3.1.2.1 Prescription Drugs
3.1.2.2 OTC Drugs
3.1.3 Pfizer Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Merck
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Anti-Obesity Drugs Product Type, Application and Specification
3.2.2.1 Prescription Drugs
3.2.2.2 OTC Drugs
3.2.3 Merck 122 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 F.Hoffmann-La Roche
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Anti-Obesity Drugs Product Type, Application and Specification
3.3.2.1 Prescription Drugs
3.3.2.2 OTC Drugs
3.3.3 F.Hoffmann-La Roche 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Anti-Obesity Drugs Product Type, Application and Specification
3.4.2.1 Prescription Drugs
3.4.2.2 OTC Drugs
3.4.3 GlaxoSmithKline Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 AstraZeneca
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Anti-Obesity Drugs Product Type, Application and Specification
3.5.2.1 Prescription Drugs
3.5.2.2 OTC Drugs
3.5.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Boehringer Ingelheim
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Anti-Obesity Drugs Product Type, Application and Specification
3.6.2.1 Prescription Drugs
3.6.2.2 OTC Drugs
3.6.3 Boehringer Ingelheim Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Novo Nordisk
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Anti-Obesity Drugs Product Type, Application and Specification
3.7.2.1 Prescription Drugs
3.7.2.2 OTC Drugs
3.7.3 Novo Nordisk Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Eisai
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Anti-Obesity Drugs Product Type, Application and Specification
3.8.2.1 Prescription Drugs
3.8.2.2 OTC Drugs
3.8.3 Eisai Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Norgine
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Anti-Obesity Drugs Product Type, Application and Specification
3.9.2.1 Prescription Drugs
3.9.2.2 OTC Drugs
3.9.3 Norgine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 Arena Pharmaceuticals
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Anti-Obesity Drugs Product Type, Application and Specification
3.10.2.1 Prescription Drugs
3.10.2.2 OTC Drugs
3.10.3 Arena Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 Orexigen Therapeutics
3.12 Vivus
3.13 Alizyme
3.14 Rhythm Pharmaceuticals
3.15 Shionogi
3.16 Zafgan

4 China Anti-Obesity Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Anti-Obesity Drugs Capacity, Production and Growth (2012-2017)
4.2 China Anti-Obesity Drugs Revenue and Growth (2012-2017)
4.3 China Anti-Obesity Drugs Production, Consumption, Export and Import (2012-2017)

5 China Anti-Obesity Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Anti-Obesity Drugs Production and Market Share by Type (2012-2017)
5.2 China Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Anti-Obesity Drugs Price by Type (2012-2017)
5.4 China Anti-Obesity Drugs Production Growth by Type (2012-2017)

6 China Anti-Obesity Drugs Market Analysis by Application
6.1 China Anti-Obesity Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Anti-Obesity Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaAnti-Obesity Drugs Market Analysis by Regions (Provinces)
7.1 China Anti-Obesity Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Anti-Obesity Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Anti-Obesity Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Anti-Obesity Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Anti-Obesity Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Anti-Obesity Drugs Production, Consumption, Export and Import (2012-2017)

8 Anti-Obesity Drugs Manufacturing Cost Analysis
8.1 Anti-Obesity Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Obesity Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Obesity Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Anti-Obesity Drugs Market Forecast (2017-2022)
12.1 China Anti-Obesity Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Anti-Obesity Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Anti-Obesity Drugs Production Forecast by Type (2017-2022)
12.4 China Anti-Obesity Drugs Consumption Forecast by Application (2017-2022)
12.5 China Anti-Obesity Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Anti-Obesity Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Anti-Obesity Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Anti-Obesity Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Anti-Obesity Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Anti-Obesity Drugs
Figure China Production Market Share of Anti-Obesity Drugs by Type in 2015
Figure Product Picture of Prescription Drugs
Table Major Manufacturers of Prescription Drugs
Figure Product Picture of OTC Drugs
Table Major Manufacturers of OTC Drugs
Table Anti-Obesity Drugs Consumption Market Share by Application in 2015
Figure 6-18 Callant Examples
Figure 18-30 Adult Examples
Figure 30-60Middle-Aged Examples
Figure Others Examples
Figure China Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Anti-Obesity Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Anti-Obesity Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Anti-Obesity Drugs Capacity of Key Manufacturers in 2015
Figure China Anti-Obesity Drugs Capacity of Key Manufacturers in 2016
Table China Anti-Obesity Drugs Production of Key Manufacturers (2015 and 2016)
Table China Anti-Obesity Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Obesity Drugs Production Share by Manufacturers
Figure 2016 Anti-Obesity Drugs Production Share by Manufacturers
Table China Anti-Obesity Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Anti-Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Anti-Obesity Drugs Revenue Share by Manufacturers
Table 2016 China Anti-Obesity Drugs Revenue Share by Manufacturers
Table China Market Anti-Obesity Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Anti-Obesity Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Anti-Obesity Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti-Obesity Drugs Product Type
Figure Anti-Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti-Obesity Drugs Market Share of Top 5 Manufacturers
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Anti-Obesity Drugs Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Anti-Obesity Drugs Market Share (2012-2017)
Table F.Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F.Hoffmann-La Roche Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Anti-Obesity Drugs Market Share (2012-2017)
Table Norgine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Norgine Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Norgine Anti-Obesity Drugs Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Anti-Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Market Share (2012-2017)
Table Orexigen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vivus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alizyme Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rhythm Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shionogi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zafgan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Anti-Obesity Drugs Capacity, Production and Growth (2012-2017)
Figure China Anti-Obesity Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Anti-Obesity Drugs Production, Consumption, Export and Import (2012-2017)
Table China Anti-Obesity Drugs Production by Type (2012-2017)
Table China Anti-Obesity Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Anti-Obesity Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Anti-Obesity Drugs by Type
Table China Anti-Obesity Drugs Revenue by Type (2012-2017)
Table China Anti-Obesity Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Anti-Obesity Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Anti-Obesity Drugs by Type
Table China Anti-Obesity Drugs Price by Type (2012-2017)
Figure China Anti-Obesity Drugs Production Growth by Type (2012-2017)
Table China Anti-Obesity Drugs Consumption by Application (2012-2017)
Table China Anti-Obesity Drugs Consumption Market Share by Application (2012-2017)
Figure China Anti-Obesity Drugs Consumption Market Share by Application in 2015
Table China Anti-Obesity Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Anti-Obesity Drugs Consumption Growth Rate by Application (2012-2017)
Table China Anti-Obesity Drugs Production by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Anti-Obesity Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure China Anti-Obesity Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Anti-Obesity Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Anti-Obesity Drugs Production Forecast by Type (2017-2022)
Table China Anti-Obesity Drugs Consumption Forecast by Application (2017-2022)
Table China Anti-Obesity Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Anti-Obesity Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Anti-Obesity Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *